Market Research

Intelligent Transportation System Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Component (Hardware, Software, Services); By Solution (Advanced Transportation Management Systems (ATMS), Advanced Trav

Best Price Guarantee Length Publisher Published Date SKU
from $4,850 400 Pages BlueWeave Consulting May, 2023 BLWC17975478
Best Price Guarantee
Price from $4,850
Length 400 Pages
Publisher BlueWeave Consulting
Published Date May, 2023
SKU BLWC17975478

Intelligent Transportation System Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Component (Hardware, Software, Services); By Solution (Advanced Transportation Management Systems (ATMS), Advanced Traveler Information Systems (ATIS), Advanced Vehicle Control Systems (AVCS), Advanced Public Transportation Systems (APTS), Cooperative Vehicle Systems (CVS)); By Application (Traffic Management, Road Safety & Security, Freight Management, Public Transport Management); By Region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa)


Global Intelligent Transportation System Market Size Set to Cross USD 57.6 Billion by 2029

Global intelligent transportation system market is flourishing because of increasing investments in transportation infrastructure and the implementations by governments, rapid urbanization, and the exploding population in urban areas.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global intelligent transportation system market size at USD 35.25 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global intelligent transportation system market size to grow at a significant CAGR of 7.52% reaching a value of USD 57.61 billion by 2029. Major growth factors of the global intelligent transportation system market include an increasing demand for efficient and sustainable transportation systems. It has led to a growing need for advanced technologies, such as traffic control systems, modern cameras, license plate readers, and smart vehicles connected to the latest telecommunications technology. It aims to enhance safety and surveillance. Another key factor expected to propel market growth is the rising number of vehicles, coupled with outdated infrastructure and inadequate traffic data management. To address these issues, a new traffic management system has been developed, and transportation authorities are leveraging modern data analytics to manage the growing volume of traffic. These initiatives are expected to fuel the expansion of the global intelligent transportation system market during the period under analysis.

Global Intelligent Transportation System Market – Overview


Global intelligent transportation system (ITS) market refers to the use of advanced technologies, communication devices, and management strategies to improve the efficiency, safety, and sustainability of transportation systems. These systems typically integrate data from various sources, such as vehicles, infrastructure, and passengers, to provide real-time information and support decision-making for transportation operators and travelers. The ITS market includes various applications, such as advanced traffic management systems, electronic toll collection systems, intelligent parking systems, and smart public transportation systems, among others. The market is driven by factors such as increasing urbanization, rising demand for efficient transportation systems, and government initiatives to reduce traffic congestion and promote sustainable transportation.

Impact of COVID -19 on Global Intelligent Transportation System Market


COVID-19 had a detrimental impact on the global intelligent transportation system (ITS) market. The pandemic led to a significant reduction in travel demand as countries imposed lockdowns and restrictions on movement to curb the spread of the virus. As a result, the demand for ITS applications such as traffic management systems, electronic toll collection, and smart public transportation systems decreased significantly. Moreover, the disruption of global supply chains caused by the pandemic led to delays in the delivery of ITS components and equipment, affecting the implementation of ITS projects. Additionally, the economic downturn caused by the pandemic resulted in budget cuts for ITS projects in many regions, further hampering market growth. The COVID-19 pandemic, on the other hand, also accelerated the adoption of digital technologies, including ITS applications, as governments and transportation operators sought to promote contactless transactions and minimize physical interactions. It led to the development of new ITS solutions, such as mobile payment systems and digital ticketing for public transportation.

Global Intelligent Transportation System Market – By Application


Based on application, the global intelligent transportation system market is divided into Traffic Management, Road Safety and Security, Freight Management, and Public Transport Management segments. The traffic management segment held the highest market share in 2022. The segment includes systems that improve the reliability and operational efficiency of road networks, such as vehicle detection systems, bridge traffic management systems, and ramp metering systems. Traffic congestion is a recurring issue worldwide, resulting in significant monetary losses due to increased travel time and fuel consumption, as well as a decreased quality of life. Thus, it is crucial for governments worldwide to introduce new technologies and implement intelligent transportation systems to reduce the financial burden and drive market demand.

Competitive Landscape

Major players operating in the global intelligent transportation system market include Thales Group, Kapsch TrafficCom AG, Siemens AG, TomTom International BV, Q-Free ASA, Hitachi Ltd., Garmin Ltd., Cubic Corporation, Denso Corporation, Iteris Inc., TransCore LP, WS Atkins PLC, Lanner Electronics Inc., EFKON AG, and Xerox Corporation. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Intelligent Transportation System Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Intelligent Transportation System Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.


1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Global Minimal Residual Disease Testing Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Growing prevalence of cancer worldwide, leading to increased demand for accurate and reliable diagnostic tests
3.2.1.2. Increasing adoption of precision medicine approaches
3.2.1.3. Growing trend towards early cancer diagnosis and detection
3.2.2. Restraints
3.2.2.1. Limited availability of skilled healthcare professionals to perform and interpret MRD tests
3.2.2.2. Concerns over the accuracy and reliability of MRD tests
3.2.3. Opportunities
3.2.3.1. Increasing adoption of advanced technologies, such as next-generation sequencing
3.2.3.2. Growing trend towards personalized cancer care, which requires accurate and reliable measurement
3.2.4. Challenges
3.2.4.1. Need for continuous investment in research and development to stay competitive
3.3. Technology Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter’s Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Global Minimal Residual Disease Testing Market Overview
4.1. Market Size & Forecast, 2019–2029
4.1.1. By Value (USD Million)
4.2. Market Share and Forecast
4.2.1. By Test Type
4.2.1.1. DNA-Based Test
4.2.1.2. RNA-Based Test
4.2.1.3. Immunological Test
4.2.1.4. Others
4.2.2. By Technology
4.2.2.1. NGS, PCR
4.2.2.2. Flow Cytometry
4.2.2.3. Fluorescence In-Situ Hybridization
4.2.2.4. Others
4.2.3. By Application
4.2.3.1. Hematological Malignancies
4.2.3.2. Solid Tumors
4.2.3.3. Others
4.2.4. By End Use
4.2.4.1. Hospitals
4.2.4.2. Specialty Clinics
4.2.4.3. Diagnostic Laboratories
4.2.4.4. Research and Academic Institutes
4.2.4.5. Others
4.2.5. By Region
4.2.5.1. North America
4.2.5.2. Europe
4.2.5.3. Asia Pacific (APAC)
4.2.5.4. Latin America (LATAM)
4.2.5.5. Middle East and Africa (MEA)
5. North America Minimal Residual Disease Testing Market
5.1. Market Size & Forecast, 2019–2029
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Test Type
5.2.2. By Technology
5.2.3. By Application
5.2.4. By End Use
5.2.5. By Country
5.2.5.1. United States
5.2.5.1.1. By Test Type
5.2.5.1.2. By Technology
5.2.5.1.3. By Application
5.2.5.1.4. By End Use
5.2.5.2. Canada
5.2.5.2.1. By Test Type
5.2.5.2.2. By Technology
5.2.5.2.3. By Application
5.2.5.2.4. By End Use
6. Europe Minimal Residual Disease Testing Market
6.1. Market Size & Forecast, 2019–2029
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Test Type
6.2.2. By Technology
6.2.3. By Application
6.2.4. By End Use
6.2.5. By Country
6.2.5.1. Germany
6.2.5.1.1. By Test Type
6.2.5.1.2. By Technology
6.2.5.1.3. By Application
6.2.5.1.4. By End Use
6.2.5.2. United Kingdom
6.2.5.2.1. By Test Type
6.2.5.2.2. By Technology
6.2.5.2.3. By Application
6.2.5.2.4. By End Use
6.2.5.3. Italy
6.2.5.3.1. By Test Type
6.2.5.3.2. By Technology
6.2.5.3.3. By Application
6.2.5.3.4. By End Use
6.2.5.4. France
6.2.5.4.1. By Test Type
6.2.5.4.2. By Technology
6.2.5.4.3. By Application
6.2.5.4.4. By End Use
6.2.5.5. Spain
6.2.5.5.1. By Test Type
6.2.5.5.2. By Technology
6.2.5.5.3. By Application
6.2.5.5.4. By End Use
6.2.5.6. Belgium
6.2.5.6.1. By Test Type
6.2.5.6.2. By Technology
6.2.5.6.3. By Application
6.2.5.6.4. By End Use
6.2.5.7. Russia
6.2.5.7.1. By Test Type
6.2.5.7.2. By Technology
6.2.5.7.3. By Application
6.2.5.7.4. By End Use
6.2.5.8. The Netherlands
6.2.5.8.1. By Test Type
6.2.5.8.2. By Technology
6.2.5.8.3. By Application
6.2.5.8.4. By End Use
6.2.5.9. Rest of Europe
6.2.5.9.1. By Test Type
6.2.5.9.2. By Technology
6.2.5.9.3. By Application
6.2.5.9.4. By End Use
7. Asia-Pacific Minimal Residual Disease Testing Market
7.1. Market Size & Forecast, 2019–2029
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Test Type
7.2.2. By Technology
7.2.3. By Application
7.2.4. By End Use
7.2.5. By Country
7.2.5.1. China
7.2.5.1.1. By Test Type
7.2.5.1.2. By Technology
7.2.5.1.3. By Application
7.2.5.1.4. By End Use
7.2.5.2. India
7.2.5.2.1. By Test Type
7.2.5.2.2. By Technology
7.2.5.2.3. By Application
7.2.5.2.4. By End Use
7.2.5.3. Japan
7.2.5.3.1. By Test Type
7.2.5.3.2. By Technology
7.2.5.3.3. By Application
7.2.5.3.4. By End Use
7.2.5.4. South Korea
7.2.5.4.1. By Test Type
7.2.5.4.2. By Technology
7.2.5.4.3. By Application
7.2.5.4.4. By End Use
7.2.5.5. Australia & New Zealand
7.2.5.5.1. By Test Type
7.2.5.5.2. By Technology
7.2.5.5.3. By Application
7.2.5.5.4. By End Use
7.2.5.6. Indonesia
7.2.5.6.1. By Test Type
7.2.5.6.2. By Technology
7.2.5.6.3. By Application
7.2.5.6.4. By End Use
7.2.5.7. Malaysia
7.2.5.7.1. By Test Type
7.2.5.7.2. By Technology
7.2.5.7.3. By Application
7.2.5.7.4. By End Use
7.2.5.8. Singapore
7.2.5.8.1. By Test Type
7.2.5.8.2. By Technology
7.2.5.8.3. By Application
7.2.5.8.4. By End Use
7.2.5.9. Vietnam
7.2.5.9.1. By Test Type
7.2.5.9.2. By Technology
7.2.5.9.3. By Application
7.2.5.9.4. By End Use
7.2.5.10. Rest of APAC
7.2.5.10.1. By Test Type
7.2.5.10.2. By Technology
7.2.5.10.3. By Application
7.2.5.10.4. By End Use
8. Latin America Minimal Residual Disease Testing Market
8.1. Market Size & Forecast, 2019–2029
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Test Type
8.2.2. By Technology
8.2.3. By Application
8.2.4. By End Use
8.2.5. By Country
8.2.5.1. Brazil
8.2.5.1.1. By Test Type
8.2.5.1.2. By Technology
8.2.5.1.3. By Application
8.2.5.1.4. By End Use
8.2.5.2. Mexico
8.2.5.2.1. By Test Type
8.2.5.2.2. By Technology
8.2.5.2.3. By Application
8.2.5.2.4. By End Use
8.2.5.3. Argentina
8.2.5.3.1. By Test Type
8.2.5.3.2. By Technology
8.2.5.3.3. By Application
8.2.5.3.4. By End Use
8.2.5.4. Peru
8.2.5.4.1. By Test Type
8.2.5.4.2. By Technology
8.2.5.4.3. By Application
8.2.5.4.4. By End Use
8.2.5.5. Rest of LATAM
8.2.5.5.1. By Test Type
8.2.5.5.2. By Technology
8.2.5.5.3. By Application
8.2.5.5.4. By End Use
9. Middle East & Africa Minimal Residual Disease Testing Market
9.1. Market Size & Forecast, 2019–2029
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Test Type
9.2.2. By Technology
9.2.3. By Application
9.2.4. By End Use
9.2.5. By Country
9.2.5.1. Saudi Arabia
9.2.5.1.1. By Test Type
9.2.5.1.2. By Technology
9.2.5.1.3. By Application
9.2.5.1.4. By End Use
9.2.5.2. UAE
9.2.5.2.1. By Test Type
9.2.5.2.2. By Technology
9.2.5.2.3. By Application
9.2.5.2.4. By End Use
9.2.5.3. Qatar
9.2.5.3.1. By Test Type
9.2.5.3.2. By Technology
9.2.5.3.3. By Application
9.2.5.3.4. By End Use
9.2.5.4. Kuwait
9.2.5.4.1. By Test Type
9.2.5.4.2. By Technology
9.2.5.4.3. By Application
9.2.5.4.4. By End Use
9.2.5.5. South Africa
9.2.5.5.1. By Test Type
9.2.5.5.2. By Technology
9.2.5.5.3. By Application
9.2.5.5.4. By End Use
9.2.5.6. Nigeria
9.2.5.6.1. By Test Type
9.2.5.6.2. By Technology
9.2.5.6.3. By Application
9.2.5.6.4. By End Use
9.2.5.7. Algeria
9.2.5.7.1. By Test Type
9.2.5.7.2. By Technology
9.2.5.7.3. By Application
9.2.5.7.4. By End Use
9.2.5.8. Rest of MEA
9.2.5.8.1. By Test Type
9.2.5.8.2. By Technology
9.2.5.8.3. By Application
9.2.5.8.4. By End Use
10. Competitive Landscape
10.1. List of Key Players and Their Offerings
10.2. Global Minimal Residual Disease Testing Market Share Analysis, 2022
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Covid-19 on Global Minimal Residual Disease Testing Market
12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
12.1. Abbott Laboratories
12.2. Adaptive Biotechnologies
12.3. Agilent Technologies
12.4. ARUP Laboratories
12.5. Bio-Rad Laboratories
12.6. F. Hoffmann-La Roche AG
12.7. Illumina, Inc.
12.8. Invivoscribe, Inc.
12.9. Janssen Diagnostics LLC
12.10. Luminex Corporation
12.11. Myriad Genetics, Inc.
12.12. Natera, Inc.
12.13. QIAGEN N.V.
12.14. Sysmex Corporation
12.15. Thermo Fisher Scientific, Inc.
12.16. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology
14.1. Qualitative Research
14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
14.3.1. Secondary Research
14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations

$4,850
$5,750
$8,150

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings